Correlation Between Monte Rosa and Monopar Therapeutics

Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Monte Rosa Therapeutics and Monopar Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Monopar Therapeutics.

Diversification Opportunities for Monte Rosa and Monopar Therapeutics

0.68

Correlation Coefficient

Monte Rosa  Monopar Therapeutics

Poor diversification

The 3 months correlation between Monte and Monopar is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Monopar Therapeutics go up and down completely randomly.

Pair Corralation between Monte Rosa and Monopar Therapeutics

Given the investment horizon of 90 days Monte Rosa is expected to generate 14.02 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Monte Rosa Therapeutics is 5.92 times less risky than Monopar Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  437.00  in Monopar Therapeutics on September 21, 2024 and sell it today you would earn a total of  2,294  from holding Monopar Therapeutics or generate 525.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Monte Rosa Therapeutics  vs.  Monopar Therapeutics

Monte Rosa Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

Monopar Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Monte Rosa and Monopar Therapeutics

The main advantage of trading using opposite Monte Rosa and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.

The idea behind Monte Rosa Therapeutics and Monopar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .